Lttl
Lttl is a U.S. telehealth service offering clinician-prescribed GLP-1 weight loss, longevity peptides and microdosing plans, with no insurance required and free shipping.
About Lttl
Lttl: clinician-led GLP-1 weight loss, longevity and microdosing
Lttl is a U.S. telehealth provider that combines three lines of care in one service: GLP-1 weight management, longevity protocols and microdosed therapy. The company states that its treatments are prescribed by licensed U.S. clinicians and compounded by U.S.A. licensed pharmacies. Plans are reviewed by a clinician, require no insurance and carry no contracts, and the service includes unlimited 24/7 support and free shipping. The site also states that prescriptions are shipped within 48 hours.
How the service works
The process is structured in three steps. First, the user completes a free two-minute assessment with questions about goals and medical background. A licensed clinician then reviews the answers and creates a personalised plan. Finally, the prescription is delivered to the patient's door with free shipping. The site presents the model as clinician-reviewed, with no hidden fees and the same price at every dose.
Weight loss plans
The weight loss line is built around two GLP-1 options. Tirzepatide, described as a dual-action GLP-1 + GIP treatment, starts at $139/mo and is presented as the most powerful option, designed for accelerated results and fewer side effects. Semaglutide, a GLP-1 treatment, starts at $89/mo and is positioned as a proven, steady option for first-time users. The site reports that average Lttl members lose 32 lbs in six months; top responders lose 55+ lbs in 12 months on tirzepatide and 44+ lbs in 12 months on semaglutide. It also states that 62% of members choose tirzepatide and 36% choose semaglutide.
Longevity peptides and support compounds
The longevity range includes injectable, nasal and oral formats. NAD+ is offered as an injectable at $99/mo, described as supporting cellular energy and maximum energy and focus, with 100% bioavailability via injection; members reportedly feel more energy in two weeks. A needle-free NAD+ nasal spray at $99/mo is presented as fast-acting, with onset in under 10 minutes. NAD+ oral liquid at $99/mo uses a liposomal formula for daily support. Sermorelin, a growth hormone support peptide, starts at $99/mo and is described as stimulating natural growth hormone, with members reporting better sleep within four weeks. Glutathione at $79/mo is positioned as a master antioxidant and detox support, with members noticing clearer skin in 30 days. MIC+B12 at $79/mo combines methionine, inositol, choline and B12 for energy and fat metabolism. Methylene Blue at $79/mo is a low-dose oral pharmaceutical-grade option for cognitive and mitochondrial support. L-Carnitine at $79/mo is an amino acid for fat metabolism, endurance and recovery.
Microdosing
The microdose line offers lower-dose versions of the GLP-1 treatments. Microdose semaglutide starts at $109/mo and is designed for minimal side effects, steady gradual weight loss and sensitive starters. Microdose tirzepatide, also at $109/mo, provides dual-action GLP-1 + GIP support with a gentler metabolic ramp-up and is preferred by side-effect-sensitive members. Both maintain the same price at every dose.
Positioning and recognition
The site describes Lttl as "#1 Rated for Best Results" and states that it was named Forbes Health's Best Provider of 2026. It also reports that more than 500,000 people have joined its GLP-1 journey. These claims are presented as the company's own statements. The service is aimed at users seeking clinician-prescribed GLP-1 treatment, longevity peptides or microdosed therapy without insurance or long-term contracts.
Telehealth GLP-1 weight loss and longevity peptides
Photos

